Blueberries Medical Announces Closing of C$2 Million Non-Brokered Private Placement
December 29, 2023 17:00 ET
|
Blueberries Medical Corp.
TORONTO, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
Blueberries Medical Announces C$2 Million Non-Brokered Private Placement
December 15, 2023 17:00 ET
|
Blueberries Medical Corp.
TORONTO, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
Blueberries Medical Reports Q1-2023
May 30, 2023 10:35 ET
|
Blueberries Medical Corp.
TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), a leading player in the cannabis industry...
Blueberries Medical Reports 2022 Financial Results
April 24, 2023 16:18 ET
|
Blueberries Medical Corp.
TORONTO, April 24, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...
Blueberries Medical Announces Closing of US$1.1 Million Non-Brokered Private Placement, reports 2022 Q3 Financial Results and provides Corporate and Operations Update
November 28, 2022 17:00 ET
|
Blueberries Medical Corp.
TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”), a Latin American licensed producer of medicinal cannabis and...
Blueberries Medical Reports 2022 Q2 Financial Results and Provides Corporate and Operations Update
August 25, 2022 17:51 ET
|
Blueberries Medical Corp.
TORONTO, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...
Blueberries Medical Announces the launch of new markets for its products, partnerships in agronomic operation and the Extension of Maturity Date of Convertible Debenture
July 29, 2022 09:19 ET
|
Blueberries Medical Corp.
TORONTO, July 29, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and...
Blueberries Medical Reports 2022 Q1 Financial Results and Provides Corporate and Operations Update
May 30, 2022 17:23 ET
|
Blueberries Medical Corp.
TORONTO, May 30, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...
Blueberries Medical Reports 2021 Financial Results
May 03, 2022 22:10 ET
|
Blueberries Medical Corp.
TORONTO, May 03, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...
Blueberries Medical Reports 2021 Q3 Financial Results and Provides Corporate and Operations Update
November 29, 2021 07:30 ET
|
Blueberries Medical Corp.
TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“BBSAS”), the premier Latin American licensed...